tiprankstipranks
Trending News
More News >
Avalo Therapeutics, Inc. (AVTX)
:AVTX
US Market

Avalo Therapeutics (AVTX) Cash flow

Compare
1,028 Followers

Avalo Therapeutics Cash Flow

AVTX's free cash flow for Q3 2025 was $-16.36M. For the 2025 fiscal year, AVTX's free cash flow was decreased by $-18.22M and operating cash flow was $-16.36M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -49.06M$ -30.68M$ -26.75M$ -70.89M$ -40.54M
Investing Cash Flow
$ 356.00K$ -133.00K$ -95.00K$ -113.00K$ 11.13M
Financing Cash Flow
$ 175.85M$ 25.04M$ -14.70M$ 106.76M$ 44.78M
End Cash Position
$ 134.70M$ 7.55M$ 13.19M$ 54.86M$ 19.11M
Free Cash Flow
$ -49.06M$ -30.84M$ -26.85M$ -71.00M$ -40.60M
Currency in USD

Avalo Therapeutics Cash Flow